Detalhe da pesquisa
1.
Viral Delivery of IL-7 Is a Potent Immunotherapy Stimulating Innate and Adaptive Immunity and Confers Survival in Sepsis Models.
J Immunol
; 209(1): 99-117, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667841
2.
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.
Gut
; 64(12): 1961-71, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25429051
3.
Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count.
Hum Vaccin Immunother
; 18(6): 2133914, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315906
4.
A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model.
Hum Vaccin Immunother
; 14(6): 1417-1422, 2018 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29388874
5.
Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes.
Vaccine
; 33(36): 4548-53, 2015 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26209840
6.
Comparative analysis of immunization schedules using a novel adenovirus-based immunotherapeutic targeting hepatitis B in naïve and tolerant mouse models.
Vaccine
; 32(26): 3256-63, 2014 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24726690